Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.
Patil SB, Tamirat M, Khazhidinov K, Ardizzoni E, Atger M, Austin A, Baudin E, Bekhit M, Bektasov S, Berikova E, Bonnet M, Caboclo R, Chaudhry M, Chavan V, Cloez S, Coit J, Coutisson S, Dakenova Z, De Jong BC, Delifer C, Demaisons S, Do JM, Dos Santos Tozzi D, Ducher V, Ferlazzo G, Gouillou M, Khan U, Kunda M, Lachenal N, LaHood AN, Lecca L, Mazmanian M, McIlleron H, Moreau M, Moschioni M, Nahid P, Osso E, Oyewusi L, Panda S, Pâquet A, Thuong Huu P, Pichon L, Rich ML, Rupasinghe P, Salahuddin N, Sanchez Garavito E, Seung KJ, Velásquez GE, Vallet M, Varaine F, Yuya-Septoh FJ, Mitnick CD, Guglielmetti L. Patil SB, et al. Among authors: chavan v. Trials. 2023 Nov 30;24(1):773. doi: 10.1186/s13063-023-07701-6. Trials. 2023. PMID: 38037119 Free PMC article.
Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges.
Chavan VV, Dalal A, Nagaraja S, Thekkur P, Mansoor H, Meneguim A, Paryani R, Singh P, Kalon S, Das M, Ferlazzo G, Isaakidis P. Chavan VV, et al. PLoS One. 2020 Jun 16;15(6):e0234651. doi: 10.1371/journal.pone.0234651. eCollection 2020. PLoS One. 2020. PMID: 32544174 Free PMC article.
Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India.
Dhakulkar S, Das M, Sutar N, Oswal V, Shah D, Ravi S, Vengurlekar D, Chavan V, Rebello L, Meneguim AC, Iyer A, Mansoor H, Kalon S, Acharya S, Ferlazzo G, Isaakidis P, Thakur HP. Dhakulkar S, et al. Among authors: chavan v. PLoS One. 2021 Feb 18;16(2):e0246639. doi: 10.1371/journal.pone.0246639. eCollection 2021. PLoS One. 2021. PMID: 33600431 Free PMC article.
Clinical utility of target-based next-generation sequencing for drug-resistant TB.
Mansoor H, Hirani N, Chavan V, Das M, Sharma J, Bharati M, Oswal V, Iyer A, Morales M, Joshi A, Ferlazzo G, Isaakidis P, Ndlovu Z, England K. Mansoor H, et al. Among authors: chavan v. Int J Tuberc Lung Dis. 2023 Jan 1;27(1):41-48. doi: 10.5588/ijtld.22.0138. Int J Tuberc Lung Dis. 2023. PMID: 36853141 Free PMC article.
Treatment outcomes among patients with isoniazid mono-resistant tuberculosis in Mumbai, India: A retrospective cohort study.
Khan S, Silsarma A, Mahajan R, Khan S, Davuluri P, Sutar N, Iyer A, Mankar S, Oswal V, Puri V, Shah D, Chavan V, Spencer H, Isaakidis P. Khan S, et al. Among authors: chavan v. J Clin Tuberc Other Mycobact Dis. 2024 Oct 12;37:100481. doi: 10.1016/j.jctube.2024.100481. eCollection 2024 Dec. J Clin Tuberc Other Mycobact Dis. 2024. PMID: 39497757 Free PMC article.
Linezolid resistance in patients with drug-resistant TB.
Vengurlekar D, Walker C, Mahajan R, Dalal A, Chavan V, Galindo MA, Iyer A, Mansoor H, Silsarma A, Isaakidis P, Spencer H. Vengurlekar D, et al. Among authors: chavan v. Int J Tuberc Lung Dis. 2023 Jul 1;27(7):567-569. doi: 10.5588/ijtld.22.0632. Int J Tuberc Lung Dis. 2023. PMID: 37353865 Free PMC article. No abstract available.
Correction: Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges.
Chavan VV, Dalal A, Nagaraja S, Thekkur P, Mansoor H, Meneguim A, Paryani R, Singh P, Kalon S, Das M, Ferlazzo G, Isaakidis P. Chavan VV, et al. PLoS One. 2024 Feb 21;19(2):e0299477. doi: 10.1371/journal.pone.0299477. eCollection 2024. PLoS One. 2024. PMID: 38381762 Free PMC article.
Far-red and sensitive sensor for monitoring real time H2O2 dynamics with subcellular resolution and in multi-parametric imaging applications.
Berndt A, Lee J, Nguyen A, Jin Z, Moghadasi A, Gibbs C, Wait S, Evitts K, Asencio A, Bremner S, Zuniga S, Chavan V, Williams A, Smith A, Moussavi-Harami F, Regnier M, Young J, Mack D, Nance E, Boyle P. Berndt A, et al. Among authors: chavan v. Res Sq [Preprint]. 2024 Apr 17:rs.3.rs-3974015. doi: 10.21203/rs.3.rs-3974015/v1. Res Sq. 2024. PMID: 38699332 Free PMC article. Preprint.
136 results